Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.
Source link
Coinbase Founder’s Longevity Startup Triples in Value
Date:
Date:
Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.
Source link